Retinoids

DRUG2 trials

Sponsors

Merck KGaA, Darmstadt, Germany, Erasmus Medical Center

Conditions

Cicatricial AlopeciaFrontal Fibrosing AlopeciaHair DiseasesHair Loss/BaldnessLichen Plano-PilarisLichen PlanopilarisPsoriasisScarring Alopecia

Phase 4

Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence

CompletedNCT01079988

Merck KGaA, Darmstadt, GermanyPsoriasis

Start: 2004-02-29End: 2005-04-30Updated: 2014-02-27

Unknown Phase

a Retrospective Study on the Systemic Treatment of LPP and FFA

CompletedNCT06512766

Erasmus Medical CenterCicatricial Alopecia, Frontal Fibrosing Alopecia, Hair Diseases +4

Start: 2022-09-23End: 2023-02-01Updated: 2024-07-22